6. Kanazawa I., Sugimoto T. Diabetes Mellitus-induced Bone Fragility // Internal Medicine. 2018. Vol. 57, № 19. P. 2773-2785. doi:10.2169/internalmedicine.0905-18
7. Rees D. A., Alcolado J. C. Animal models of diabetes mellitus // Diabetic Medicine. 2005. Vol. 22, № 4. P. 359-370. doi:10.1111/j.1464-5491.2005.01499.x
8. Колб В. Г., Камышников В. С. Справочник по клинической химии. Минск : Беларусь, 1982. 336 с.
9. Торба А. В., Лузин В. И. Влияние нанесения дефекта большеберцовых костей на фоне стрептозотоцинового диабета на процессы роста в скелете ювенильных белых крыс // Український морфологічний альманах. 2015. Т. 13, № 3-4. С. 86-90.
10. Нижельский В. Е., Лузин В. И. Прочность костей скелета белых крыс при воздействии паров формальдегида в разные возрастные периоды // Проблемы экологической и медицинской генетики и клинической иммунологии. 2020. № 5 (161). C. 24-29.
11. Астраханцев Д. А., Лузин В. И. Оценка влияния концентрации марганца в материале ОК-015, имплантированном в большеберцовую кость, на изменение показателей ультраструктуры биоминералов нижней челюсти и нижнего резца // Морфологический альманах имени В. Г. Ковешникова. 2019. Т. 17, № 4. С. 91-94.
12. Barrera L. N., Cassidy A., Wang W. [et al.]. TrxR1 and GPx2 are potently induced by isothiocyanates and selenium, and mutually cooperate to protect Caco-2 cells against free radical-mediated cell death // Biochim. Biophys. Acta. 2012. Vol. 1823. P. 19141924. doi:10.1016/j.bbamcr.2012.07.007
13. Zhang Z., Zhang J., Xiao J. Selenoproteins and selenium status in bone physiology and pathology // Biochim Biophys Acta. 2014. Vol. 1840, № 11. P. 3246-3256. doi:10.1016/j.bbagen.2014.08.001
14. Roy R., Boskey A., Bonassar L. J. Processing of Type I Collagen Gels Using Non-Enzymatic Glycation // Journal of Biomedical Materials Research. Part A. 2010. Vol. 93, № 3. P. 843-851. doi:10.m02/jbm.a.32231
15. Yamamoto M., Sugimoto T. Advanced Glycation End Products, Diabetes, and Bone Strength // Current Osteoporosis Reports. 2016. Vol. 14, № 6. P. 320-326. doi:10.1007/s11914-016-0332-1
16. Romero^az C., Duarte-Montero D., Gutierrez-Romero S. A., Mendivil C. O. Diabetes and Bone Fragility // Diabetes Therapy. 2021. Vol. 12, № 1. P. 71-86. doi:10.1007/ s13300-020-00964-1
References
1. Saeedi P., Petersohn I., Salpea P. [et al.]. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 th edition. Diabetes Research and Clinical Practice. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
2. Dhaon P., Shah V.N. Type 1 diabetes and osteoporosis: A review of literature. Indian Journal of Endocrinology and Metabolism. 2014;18(2):159-165. doi:10.4103/2230- 8210.129105
3. Hamada Y., Fujii H., Fukagawa M. Role of oxidative stress in diabetic bone disorder. Bone. 2009;45(suppl. 1):S35-S38. doi:10.1016/j.bone.2009.02.004
4. Li J., Zhang Y., Zhang J. [et al.]. Oxidative Stress and Its Related Factors in Latent Autoimmune Diabetes in Adults. BioMed Research International. 2021;2021:5676363. doi:10.1155/2021/5676363
5. Costantini S., Conte C. Bone health in diabetes and prediabetes. World Journal of Diabetes. 2019;10(8):421-445. doi:10.4239/wjd.v10.i8.421
6. Kanazawa I., Sugimoto T. Diabetes Mellitus-induced Bone Fragility. Internal Medicine. 2018;57(19):2773-2785. doi:10.2169/internalmedicine.0905-18
7. Rees D.A., Alcolado J.C. Animal models of diabetes mellitus. Diabetic Medicine. 2005;22(4):359-370. doi:10.1111/j.1464-5491.2005.01499.x
8. Kolb V.G., Kamyshnikov V.S. Spravochnikpo klinicheskoy khimii = Guide to clinical chemistry. Minsk: Belarus', 1982:336.
9. Torba A.V., Luzin V.I. Influence of tibial defect inflicted against the background of streptozotocin diabetes on growth processes in the skeleton of juvenile albino rats. Ukrai'ns'kiy morfologichniy al'manakh = Ukrainian morphological almanach. 2015;13(3-4):86-90. (In Russ.)
10. Nizhel'skiy V.E., Luzin V.I. The strength of the bones of the skeleton of white rats under the influence of formaldehyde vapors in different age periods. Problemy ekologicheskoy i meditsinskoy genetiki i klinicheskoy immunologii = Issues of ecological and medical genetics and clinical immunology. 2020;(5):24-29. (In Russ.)
11. Astrakhantsev D.A., Luzin V.I. Evaluation of the effect of manganese concentration in the mineral OK-015 implanted in the tibia on the change in the parameters of the ultrastructure of biominerals in the lower jaw and lower incisor. Morfologicheskiy al'manakh imeni V. G. Koveshnikova = Morphological almanac named after V. G. Koveshnikov. 2019;17(4):91-94. (In Russ.)
12. Barrera L.N., Cassidy A., Wang W. [et al.]. TrxR1 and GPx2 are potently induced by isothiocyanates and selenium, and mutually cooperate to protect Caco-2 cells against free radical-mediated cell death. Biochim. Biophys. Acta. 2012;1823:1914-1924. doi:10.1016/j.bbamcr.2012.07.007
13. Zhang Z., Zhang J., Xiao J. Selenoproteins and selenium status in bone physiology and pathology. Biochim Biophys Acta. 2014;1840(11):3246-3256. doi:10.1016/j.bbagen. 2014.08.001
14. Roy R., Boskey A., Bonassar L.J. Processing of Type I Collagen Gels Using Non- Enzymatic Glycation. Journal of Biomedical Materials Research. Part A. 2010;93(3): 843-851. doi:10.1002/jbm.a.32231
15. Yamamoto M., Sugimoto T. Advanced Glycation End Products, Diabetes, and Bone Strength. Current Osteoporosis Reports. 2016;14(6):320-326. doi:10.1007/s11914-016- 0332-1
16. Romero^az C., Duarte-Montero D., Gutierrez-Romero S.A., Mendivil C.O. Diabetes and Bone Fragility. Diabetes Therapy. 2021;12(1):71-86. doi:10.1007/s13300-020- 00964-1